Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-12 MEIER RICHARD A Director Exercise or conversion +8,500 $67.81 $576K 117,494
2023-05-12 MEIER RICHARD A Director Shares withheld for taxes −6,137 $93.93 $576K 111,357
2023-05-12 MEIER RICHARD A Director Exercise or conversion · Stock Option (Right to Buy Common Stock) −8,500 0
2023-05-12 HERON ELAINE J Director Exercise or conversion +8,500 $67.81 $576K 94,068
2023-05-12 HERON ELAINE J Director Shares withheld for taxes −6,137 $93.93 $576K 87,931
2023-05-12 HERON ELAINE J Director Exercise or conversion · Stock Option (Right to Buy Common Stock) −8,500 0
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +39,130 $67.81 $2.7M 465,343
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +7,370 $67.81 $500K 472,713
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −6,337 $93.93 $595K 466,376
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −33,644 $93.93 $3.2M 432,732
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) −39,130 0
2023-05-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) −7,370 0
2023-05-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion 10b5-1 +30,000 $67.81 $2.0M 456,213
2023-05-11 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −24,439 $94.55 $2.3M 431,774
2023-05-11 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −5,561 $95.22 $530K 426,213
2023-05-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −30,000 39,130
2023-05-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion 10b5-1 +30,000 $67.81 $2.0M 456,213
2023-05-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −21,453 $94.65 $2.0M 434,760
2023-05-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale 10b5-1 −8,547 $95.34 $815K 426,213
2023-05-09 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion 10b5-1 +30,000 $67.81 $2.0M 456,213

Page 14 of 23 · 450 trades